Applied Drug Research, Clinical Trials and Regulatory Affairs
Volume 8, 3 Issues, 2021
ISSN: 2667-338X (Online)
ISSN: 2667-3371 (Print)
This journal supports open access
ISSN: 2667-338X (Online)
ISSN: 2667-3371 (Print)
This journal supports open access
Contents
Applied Clinical Research, Clinical Trials and Regulatory Affairs (Discontinued), Volume 2 - Number 3
Editorial Open Access
Editorial Open Access
Pharma Emerging Market’s Scaning by Look and Feel of its Opportunities and Challenges
, 2(3): 115 - 122Parveen Kumar, Swagat Tripathy and Harish Dureja
DOI: 10.2174/2213476X03666151125220257
Comparative Account of Quality Management and Regulatory Aspects of Products with Health Claims: Existing Approaches and Future Challenges for Probiotics and Herbal Products
, 2(3): 123 - 132Malika Arora and Ashish Baldi
DOI: 10.2174/2213476X02666151103213351
Comparative Account of Quality Management and Regulatory Aspects of Products with Health Claims: Existing Approaches and Future Challenges for Probiotics and Herbal Products
Drug and Cosmetic Amendment Bill in India: A Promising Hope for Healthy Medical Device Regulatory Environment
, 2(3): 133 - 136Dimple Chaudhary, Swagat Tripathy and Harish Dureja
DOI: 10.2174/2213476X02666150908210025
Drug and Cosmetic Amendment Bill in India: A Promising Hope for Healthy Medical Device Regulatory Environment
Regulations of Cosmetics Across the Globe
, 2(3): 137 - 144Shivaji Rai, Apeksha Gupta and Vikas Punetha
DOI: 10.2174/2213476X03666151125220117
Product Life Cycle Management for Pharmaceutical Innovation
, 2(3): 145 - 152Swagat Tripathy, Vandana Prajapati and VijayaKumar Sengodan Guruswamy
DOI: 10.2174/2213476X03666160112001136
Product Life Cycle Management for Pharmaceutical Innovation
Anti-Monopoly and Competition Laws - Impact on the Indian Pharmaceutical Industry
, 2(3): 153 - 157Prerna Kaushik, Swagat Tripathy, Rishi Sharma and Harish Dureja
DOI: 10.2174/2213476X0203160219101526
Anti-Monopoly and Competition Laws - Impact on the Indian Pharmaceutical Industry
Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities
, 2(3): 158 - 164Ajmer S. Grewal, Viney Lather, Shashikant Bhardwaj and Deepti Pandita
DOI: 10.2174/2213476X03666151221210747
Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities
Good Manufacturing Practice Regulations for Probiotic Based Pharmaceuticals: Current Scenario and Suggestive Recommendations
, 2(3): 165 - 175Malika Arora and Ashish Baldi
DOI: 10.2174/2213476X03666160127001910
Good Manufacturing Practice Regulations for Probiotic Based Pharmaceuticals: Current Scenario and Suggestive Recommendations
Enhanced Globalization and Speed to Market for Innovative Medicines
, 2(3): 176 - 185Leticia Delgado-Herrera, Natalie Boone, Judy Kannenberg, Marcel van Gelderen, Keiichirou Ogawa, Mary Beth Blauwet, Marlowe J Schneidkraut, Sabine Agena, Raymond van Aarle, Yosuke Kubota, Marjan van der Werf-Pieters, Ivanka Baaij and Salim Mujais
DOI: 10.2174/2213476X03666160127001615
Enhanced Globalization and Speed to Market for Innovative Medicines
Acknowledgement Open Access
Editor-in-Chief
Satish C. Nair
Tawam Hospital
Al Ain
(UAE)
Tawam Hospital
Al Ain
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Applied Clinical Research, Clinical Trials and Regulatory Affairs, was introduced in 2014 and later renamed in 2020 as Applied Drug Research, Clinical Trials and Regulatory Affairs with the assistance of Dr. Satish C. Nair, who is the current Editor-in-Chief serving since 2014.
Advertisement
Webmaster Contact: info@benthamscience.net